RLAY RELAY THERAPEUTICS INC Product Launches 8-K Filing 2023 - Clinical Data Announcement Relay Therapeutics announced initial clinical data for RLY-4008 in patients with FGFR2-altered solid tumors, showing promising efficacy signals across multiple tumor types.Get access to all SEC 8-K filings of the RELAY THERAPEUTICS INC